High flow nasal cannula (HFNC) versus nasal continuous positive airway pressure (nCPAP) for the initial respiratory management of acute viral bronchiolitis in young infants: a multicenter randomized controlled trial (TRAMONTANE study)

Intensive Care Medicine - Tập 43 - Trang 209-216 - 2017
Christophe Milési1, Sandrine Essouri2, Robin Pouyau3, Jean-Michel Liet4, Mickael Afanetti5, Aurélie Portefaix3,6, Julien Baleine1, Sabine Durand1, Clémentine Combes1, Aymeric Douillard7, Gilles Cambonie1
1Pediatric Intensive Care Unit, Département de Pédiatrie Néonatale et Réanimations, CHU de Montpellier, Arnaud de Villeneuve University Hospital, Montpellier Cedex 5, France
2Pediatric Intensive Care Unit, Kremlin Bicêtre University Hospital, Paris, France
3Pediatric Intensive Care Unit, Women-Mothers and Children’s University Hospital, Lyon, France
4Pediatric Intensive Care Unit, Women and Children’s University Hospital, Nantes, France
5Pediatric Intensive Care Unit, Lenval University Hospital, Nice, France
6INSERM, CIC1407, Bron, France
7Department of Medical Information, Arnaud de Villeneuve University Hospital, Montpellier, France

Tóm tắt

Nasal continuous positive airway pressure (nCPAP) is currently the gold standard for respiratory support for moderate to severe acute viral bronchiolitis (AVB). Although oxygen delivery via high flow nasal cannula (HFNC) is increasingly used, evidence of its efficacy and safety is lacking in infants. A randomized controlled trial was performed in five pediatric intensive care units (PICUs) to compare 7 cmH2O nCPAP with 2 L/kg/min oxygen therapy administered with HFNC in infants up to 6 months old with moderate to severe AVB. The primary endpoint was the percentage of failure within 24 h of randomization using prespecified criteria. To satisfy noninferiority, the failure rate of HFNC had to lie within 15% of the failure rate of nCPAP. Secondary outcomes included success rate after crossover, intubation rate, length of stay, and serious adverse events. From November 2014 to March 2015, 142 infants were included and equally distributed into groups. The risk difference of −19% (95% CI −35 to −3%) did not allow the conclusion of HFNC noninferiority (p = 0.707). Superiority analysis suggested a relative risk of success 1.63 (95% CI 1.02–2.63) higher with nCPAP. The success rate with the alternative respiratory support, intubation rate, durations of noninvasive and invasive ventilation, skin lesions, and length of PICU stay were comparable between groups. No patient had air leak syndrome or died. In young infants with moderate to severe AVB, initial management with HFNC did not have a failure rate similar to that of nCPAP. This clinical trial was recorded in the National Library of Medicine registry (NCT 02457013).

Tài liệu tham khảo

Hall CB, Simőes EA, Anderson LJ (2013) Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol 372:39–57 Pierce HC, Mansbach JM, Fisher ES et al (2015) Variability of intensive care management for children with bronchiolitis. Hosp Pediatr 5:175–184 Hammer J, Numa A, Newth CJ (1997) Acute respiratory distress syndrome caused by respiratory syncytial virus. Pediatr Pulmonol 23:176–183 Stokes GM, Milner AD, Groggins RC (1981) Work of breathing, intra-thoracic pressure and clinical findings in a group of babies with bronchiolitis. Acta Paediatr Scand 70:689–694 Cambonie G, Milési C, Jaber S et al (2008) Nasal continuous positive airway pressure decreases respiratory muscles overload in young infants with severe acute viral bronchiolitis. Intensive Care Med 34:1865–1872 Essouri S, Durand P, Chevret L et al (2011) Optimal level of nasal continuous positive airway pressure in severe viral bronchiolitis. Intensive Care Med 37:2002–2007 Pham TM, O’Malley L, Mayfield S, Martin S, Schibler A (2015) The effect of high flow nasal cannula therapy on the work of breathing in infants with bronchiolitis. Pediatr Pulmonol 50:713–720 Milési C, Matecki S, Jaber S et al (2013) 6 cmH2O continuous positive airway pressure versus conventional oxygen therapy in severe viral bronchiolitis: a randomized trial. Pediatr Pulmonol 48:45–51 Borckink I, Essouri S, Laurent M et al (2014) Infants with severe respiratory syncytial virus needed less ventilator time with nasal continuous airways pressure then invasive mechanical ventilation. Acta Paediatr 103:81–85 Essouri S, Laurent M, Chevret L et al (2014) Improved clinical and economic outcomes in severe bronchiolitis with pre-emptive nCPAP ventilatory strategy. Intensive Care Med 40:84–91 Lee JH, Rehder KJ, Williford L, Cheifetz IM, Turner DA (2013) Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med 39:247–257 Schlapbach LJ, Schaefer J, Brady AM, Mayfield S, Schibler A (2014) High-flow nasal cannula (HFNC) support in interhospital transport of critically ill children. Intensive Care Med 40:592–599 Milési C, Baleine J, Matecki S et al (2013) Is treatment with a high flow nasal cannula effective in acute viral bronchiolitis? A physiologic study. Intensive Care Med 39:1088–1094 McKiernan C, Chua LC, Visintainer PF, Allen H (2010) High flow nasal cannulae therapy in infants with bronchiolitis. J Pediatr 156:634–638 Schibler A, Pham TM, Dunster KR et al (2011) Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery. Intensive Care Med 37:847–852 Abboud PA, Roth PJ, Skiles CL, Stolfi A, Rowin ME (2012) Predictors of failure in infants with viral bronchiolitis treated with high-flow, high-humidity nasal cannula therapy. Pediatr Crit Care Med 13:e343–e349 Metge P, Grimaldi C, Hassid S et al (2014) Comparison of a high-flow humidified nasal cannula to nasal continuous positive airway pressure in children with acute bronchiolitis: experience in a pediatric intensive care unit. Eur J Pediatr 173:953–958 Mayfield S, Bogossian F, O’Malley L, Schibler A (2014) High-flow nasal cannula oxygen therapy for infants with bronchiolitis: pilot study. J Paediatr Child Health 50:373–378 Bueno Campaña M, Olivares Ortiz J, Notario Muñoz C et al (2014) High flow therapy versus hypertonic saline in bronchiolitis: randomised controlled trial. Arch Dis Child 99:511–515 Hilliard TN, Archer N, Laura H et al (2012) Pilot study of vapotherm oxygen delivery in moderately severe bronchiolitis. Arch Dis Child 97:182–183 Sinha IP, McBride AK, Smith R, Fernandes RM (2015) CPAP and high-flow nasal cannula oxygen in bronchiolitis. Chest 148:810–823 Hough JL, Pham TM, Schibler A (2014) Physiologic effect of high-flow nasal cannula in infants with bronchiolitis. Pediatr Crit Care Med 15:e214–e219 Milési C, Boubal M, Jacquot A et al (2014) High-flow nasal cannula: recommendations for daily practice in pediatrics. Ann Intensive Care 4:29 Hollman G, Shen G, Zeng L et al (1998) Helium-oxygen improves clinical asthma scores in children with acute bronchiolitis. Crit Care Med 26:1731–1736 Debillon T, Zupan V, Ravault N, Magny JF, Dehan M (2001) Development and initial validation of the EDIN scale, a new tool for assessing prolonged pain in preterm infants. Arch Dis Child Fetal Neonatal Ed 85:F36–F41 Khemani RG, Rubin S, Belani S et al (2015) Pulse oximetry vs. PaO2 metrics in mechanically ventilated children: Berlin definition of ARDS and mortality risk. Intensive Care Med 41:94–102 Ganu SS, Gautam A, Wilkins B, Egan J (2012) Increase in use of non-invasive ventilation for infants with severe bronchiolitis is associated with decline in intubation rates over a decade. Intensive Care Med 38:1177–1183 Larrar S, Essouri S, Durand P et al (2006) Effects of nasal continuous positive airway pressure ventilation in infants with severe acute bronchiolitis. Arch Pediatr 13:1397–1403 Bakalli I, Celaj E, Simaku A, Kola E, Sallabanda S (2015) Predictors of noninvasive ventilation success in children with acute respiratory failure. Intensive Care Med 41:950–951 Cambonie G, Milési C, Fournier-Favre S et al (2006) Clinical effects of heliox administration for acute bronchiolitis in young infants. Chest 129:676–682 Black J, Baharestani MM, Cuddigan J et al (2007) National Pressure Ulcer Advisory Panel’s updated pressure ulcer staging system. Adv Skin Wound Care 20:269–274 Donlan M, Fontela PS, Puligandla PS (2011) Use of continuous positive airway pressure (CPAP) in acute viral bronchiolitis: a systematic review. Pediatr Pulmonol 46:736–746 Liet JM, Ducruet T, Gupta V, Cambonie G (2015) Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database Syst Rev 9:CD006915 Collett PW, Perry C, Engel LA (1985) Pressure-time product, flow, and oxygen cost of resistive breathing in humans. J Appl Physiol 58:1263–1272 Beasley JM, Jones SE (1981) Continuous positive airway pressure in bronchiolitis. Br Med J (Clin Res Ed) 283:1506–1508 Schiller O, Levy I, Pollak U, Kadmon G, Nahum E, Schonfeld T (2011) Central apnoeas in infants with bronchiolitis admitted to the paediatric intensive care unit. Acta Paediatr 100:216–219 Ricart S, Rovira N, Garcia-Garcia JJ et al (2014) Frequency of apnea and respiratory viruses in infants with bronchiolitis. Pediatr Infect Dis J 33:988–990 Alansari K, Toaimah FH, Khalafalla H, El Tatawy LA, Davidson BL, Ahmed W (2016) Caffeine for the treatment of apnea in bronchiolitis: a randomized trial. J Pediatr. doi:10.1016/j.jpeds.2016.04.060 Javouhey E, Barats A, Richard N et al (2008) Non-invasive ventilation as primary ventilatory support for infants with severe bronchiolitis. Intensive Care Med 34:1608–1614